Royal Bank of Canada’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Royal Bank of Canada’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8	Closed	–	–	7219
2015 Q3	$0	Hold	8	–	–	﹤0.01%	7068
2015 Q2	$0	Hold	8	–	–	﹤0.01%	6938
2015 Q1	$0	Sell	8 -800	-99%	-$3.15K	﹤0.01%	6687
2014 Q4	$4K	Buy	808 +800	+10,000%	+$4.21K	﹤0.01%	5885
2014 Q3	$0	Hold	8	–	–	﹤0.01%	6325
2014 Q2	$0	Buy	+8	New	+$139	﹤0.01%	6371

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 13.41% 1-Year Est. Return

Royal Bank of Canada's RCPI Position: Q4 2015 in Review

Royal Bank of Canada sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 8 shares.

Royal Bank of Canada first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $4K in Q4 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Royal Bank of Canada reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Royal Bank of Canada sold 8 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
Royal Bank of Canada first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
Royal Bank of Canada's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $4K in Q4 2014.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Royal Bank of Canada's 13F filing for Q4 2015, filed 16 Feb 2016.